Please login to the form below

Not currently logged in
Email:
Password:

Lindsay Rocco to lead corporate communications at Dendreon

Joins from agency Rx Mosaic Health

Lindsay Rocco, DendreonDendreon has appointed Rx Mosaic Health's Lindsay Rocco to executive VP, corporate communications.

The US biotech, which markets prostate cancer vaccine Provenge (sipuleucel-T), said Rocco will be responsible for all communications functions of the company, reporting directly to chair, president and CEO John Johnson.

Rocco was most recently senior VP at healthcare communications agency Rx Mosaic Health, a position she held since February 2010.

She has previous communications experience within the industry too, serving as director, public affairs at Roche, prior to her time at Rx Mosaic Health.

“Lindsay is a seasoned communicator with a deep understanding of the oncology space and a true passion for Dendreon's mission to help advanced prostate cancer patients lead longer and better lives,” said Johnson.

“Lindsay's energy and expertise in healthcare communications makes her an ideal addition to our leadership team.”

15th November 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics